TMCnet News
EOS imaging Announces New Sale to Advocate Good Samaritan Hospital in the United StatesEOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI), the pioneer in 2D/3D orthopedic medical imaging, today announced the sale of an EOS system to Advocate Good Samaritan Hospital in Downers Grove, Illinois, outside of Chicago. The hospital is a member of Advocate Healthcare, a hospital network which performs more than 18,000 hip, knee and spine procedures per year1. Advocate Healthcare hospital network is the largest health system in Illinois with 13 hospitals, including two pediatric hospitals and nine adult hospitals active in orthopedic care. The network has evolved into a nationally recognized health care leader and appeared on the 100 Top Hospitals list six times over the past seven years. In addition, it remains the only health care provider in Illinois to have earned the Malcolm Baldrige National Quality Award - the highest Presidential honor for performance excellence2. Marie Meynadier, CEO of EOS imaging, commented, "We are pleased that the EOS system and related treatment planning services are now available to patients in the greater Chicago area through the Good Samaritan Hospital and broader Advocate Healthcare network. This is another example of a prominent healthcare organization adopting our technology, providing validatio in the market and additional growth potential. To-date, seven of these large networks have acquired two or more EOS platforms3, contributing to our strong adoption momentum in the United States." For more information, please visit www.eos-imaging.com. EOS imaging has been chosen to be included in the new EnterNext© PEA-PME 150 index, composed of 150 French companies and listed on Euronext and Alternext markets in Paris.
EOS imaging is listed on Compartment C of Euronext Paris About EOS imaging EOS imaging designs, develops, and markets EOS®, an innovative medical imaging system dedicated to osteoarticular pathologies and orthopedics, as well as associated solutions. The Company is authorized to market in 51 countries, including the United States, Japan, China, and the European Union. The Group posted 2015 revenues of €21.8 million and employs 122 people. The Group is based in Paris and has five subsidiaries in Besançon (France), Cambridge (Massachusetts), Montreal (Canada), Frankfurt (Germany) and Singapore.
1 2014 data based on ICD procedure data
View source version on businesswire.com: http://www.businesswire.com/news/home/20160629006060/en/ |
